31 results on '"Warner, Allison Betof"'
Search Results
2. The features and management of acquired resistance to PD1-based therapy in metastatic melanoma
3. The “Great Debate” at Melanoma Bridge 2021, December 2nd–4th, 2021
4. Dermatologic infections in cancer patients treated with checkpoint inhibitors
5. The future of cancer immunotherapy: microenvironment-targeting combinations
6. Exercise as Adjunct Therapy in Cancer
7. Leptomeningeal Carcinomatosis from Solid Tumor Malignancies: Treatment Strategies and Biomarkers
8. 878 T cell immunotherapies recruit and activate neutrophils to eliminate tumor antigen escape variants
9. Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study
10. 578
11. Modifiable Host Factors in Melanoma: Emerging Evidence for Obesity, Diet, Exercise, and the Microbiome
12. Diversity, equity, and inclusion in the melanoma research community
13. Beyond the 5‐year milestone: Long‐term survivorship of melanoma patients treated off‐trial with anti‐PD ‐1
14. Combination Controversies: Checkpoint Inhibition Alone or in Combination for the Treatment of Melanoma?
15. Decision-Making and Health-Related Quality of Life in Patients with Melanoma Considering Adjuvant Immunotherapy
16. Tumor-Infiltrating Lymphocyte Therapy in Melanoma: Facts to the Future
17. Diversity, Equity, and Inclusion in the Melanoma Research Community
18. Inflammatory vulvar dermatoses following immune checkpoint inhibitor therapy
19. Abstract 4167: Combination of cyclophosphamide with immune checkpoint blockade inhibition elicits potent tumor control in a preclinical melanoma model
20. Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma – Authors' reply
21. Abstract 1795: Combination of cyclophosphamide chemotherapy with immune modulation overcomes resistance to checkpoint blockade in a pre-clinical melanoma model
22. Inflammatory vulvar dermatoses following immune checkpoint inhibitor therapy
23. The nature and management of acquired resistance to PD1-based therapy in melanoma.
24. ApricityRx companion digital therapeutic for evidence-based mitigation and phenotype-linked molecular characterization of irAEs in patients receiving immune checkpoint therapy (ICT).
25. A phase II study to evaluate the need for > two doses of nivolumab + ipilimumab combination (combo) immunotherapy.
26. Success and failure of additional immunosuppressants in steroid-refractory pneumonitis related to immune checkpoint blockade.
27. Selective inhibition of low-affinity memory CD8+ T cells by corticosteroids
28. Bigger Is Not Always Better: Tumor Size and Prognosis in Advanced Melanoma
29. Abstract 1699: Treatment with agonist anti-GITR antibody after chemotherapy enhances tumor immunity
30. The brim of uncertainty in adjuvant treatment of melanoma
31. Selective inhibition of low-affinity memory CD8 + T cells by corticosteroids.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.